Abstract |
Twenty-one dogs with canine superficial bacterial pyoderma were treated with clindamycin at a dosage of approximately 11 mg/kg body weight, q 24 hours, given orally for 14 to 42 days. All dogs were reexamined on days 14, 28, and, if necessary, 42 and given a clinical score of excellent (i.e., complete remission), good (i.e., primary lesions resolved but secondary lesions evident), fair (i.e., partial improvement but primary lesions still evident), or poor (i.e., no improvement or worsening of the lesions). A clinical score of excellent was obtained in 71.4% (15/21) of the dogs in this study within 14 to 28 days.
|
Authors | P B Bloom, E J Rosser |
Journal | Journal of the American Animal Hospital Association
(J Am Anim Hosp Assoc)
2001 Nov-Dec
Vol. 37
Issue 6
Pg. 537-42
ISSN: 0587-2871 [Print] United States |
PMID | 11716027
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Clindamycin
|
Topics |
- Administration, Oral
- Animals
- Anti-Bacterial Agents
(administration & dosage, pharmacology)
- Clindamycin
(administration & dosage, pharmacology)
- Dog Diseases
(drug therapy)
- Dogs
- Drug Administration Schedule
- Female
- Male
- Microbial Sensitivity Tests
- Pyoderma
(drug therapy, veterinary)
- Staphylococcal Infections
(drug therapy, veterinary)
- Staphylococcus
(drug effects)
- Treatment Outcome
|